Search results
Results from the WOW.Com Content Network
The US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 vaccines to formulate their new shots to be a better match for the JN.1 lineage of the coronavirus.
The updated vaccine is authorized for use in individuals 12 years of age and older and will target the JN.1 strain of the virus. Shares of the company were up 2.2% in extended trading after ...
Earlier this month, the health regulator approved updated COVID-19 vaccines made by Pfizer and Moderna targeting the KP.2 variant. JN.1 was the dominant strain in the United States earlier this year.
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
The FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the highly contagious JN.1 variant that spread widely in the U.S. this winter.
The vaccine candidate was able to pass the pre-clinical trials on animal models successfully. A report of the study was made available via bioRxiv and later published in the journal Vaccine . [ 2 ] [ 7 ] Thereafter, human trials for Phase I and II were approved by the regulator.
Amar Ujala was founded in Agra in 1948. [5] [6] In 1994, Amar Ujala, along with another Hindi daily, shared nearly 70 per cent of the Hindi newspaper readership in the state of Uttar Pradesh. Amar Ujala sold 4.5 lakh copies through its five editions. [7]
The New York City Department of Health and Mental Hygiene tweeted an update on vaccine availability Thursday. NEW Updated COVID-19 vaccines will be available in NYC within a few days.